Portal vein tumor thrombus (PVTT) is very common and it plays a major role in the prognosis
and clinical staging of hepatocellular carcinoma (HCC). We have published the first version …

Portal vein tumor thrombus (PVTT) is very common, and it plays a major role in the
prognosis and clinical staging of hepatocellular carcinoma (HCC). We have published the …

Hepatocellular carcinoma (HCC) is one of most prevalent cancer and is a serious healthcare
issue worldwide. Portal vein tumor thrombus (PVTT) is a frequent complication and remains …

The proportions of patients with hepatocellular carcinoma (HCC) involving portal vein tumor
thrombus (PVTT) varies greatly in different countries or regions, ranging from 13% to 45 …

Portal vein tumor thrombosis (PVTT) is a common phenomenon in hepatocellular carcinoma
(HCC). Compared to HCC without PVTT, HCC with PVTT is characterized by an aggressive …

Multimodality Treatment for Hepatocellular Carcinoma With Po... : Medicine Multimodality
Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale …

Background No consensus treatment has been reached for hepatocellular carcinoma (HCC)
with portal vein tumor thrombus (PVTT). Hepatic resection (HR) and transarterial …

Portal vein tumor thrombus is a frequent, challenging complication in hepatocellular
carcinoma. Hepatocellular carcinoma patients with portal vein tumor thrombus may show …

Background and Objectives This study aimed to compare the efficacy of transarterial
chemoembolization (TACE) plus sorafenib (TACE-S) to TACE plus lenvatinib (TACE-L) for …

BACKGROUND The efficacy and safety of transarterial chemoembolization (TACE) plus
lenvatinib in patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus …